Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Hoots

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Gene therapy for hemophilia?W K Hoots
Transfusion Medicine Reviews|July 7, 2001
Safety issues affecting hemophilia productsW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Commentary: 'switching between full-length and B-domain deleted factor VIII and the risk of inhibitors'W K Hoots
American Family Physician|September 1, 1981
Bruising and recurrent bleeding in childrenW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Urgent inhibitor issues: targets for expanded researchW K Hoots
Transfusion Medicine Reviews|July 7, 2001
History of plasma-product safetyW K Hoots
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Hemorrhage following hematopoetic stem cell transplantation--which arrows belong in the quiver?W K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2001
The future of plasma-derived clotting factor concentratesW K Hoots
Seminars in Thrombosis and Hemostasis|January 1, 1997
Experience with antithrombin concentrates in neurotrauma patientsW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2010
Human plasma-derived concentrates: preventing thrombosis and controlling haemorrhageK Lee, W K Hoots
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Gene therapy for hemophilia?W K Hoots
Transfusion Medicine Reviews|July 7, 2001
Safety issues affecting hemophilia productsW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 7, 2006
Commentary: 'switching between full-length and B-domain deleted factor VIII and the risk of inhibitors'W K Hoots
American Family Physician|September 1, 1981
Bruising and recurrent bleeding in childrenW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Urgent inhibitor issues: targets for expanded researchW K Hoots
Transfusion Medicine Reviews|July 7, 2001
History of plasma-product safetyW K Hoots
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Hemorrhage following hematopoetic stem cell transplantation--which arrows belong in the quiver?W K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 10, 2001
The future of plasma-derived clotting factor concentratesW K Hoots
Seminars in Thrombosis and Hemostasis|January 1, 1997
Experience with antithrombin concentrates in neurotrauma patientsW K Hoots
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2010
Human plasma-derived concentrates: preventing thrombosis and controlling haemorrhageK Lee, W K Hoots
Pageof 6